
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.910 | 1.910 | 0.000 |
Shares | 98.090 | 98.090 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.257 | 19.611 |
Price to Book | 3.323 | 3.844 |
Price to Sales | 2.727 | 2.221 |
Price to Cash Flow | 12.783 | 14.840 |
Dividend Yield | 1.235 | 1.499 |
5 Years Earnings Growth | 16.436 | 10.202 |
Number of long holdings: 51
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Medincell | FR0004065605 | 6.88 | 15.99 | -1.54% | |
Eli Lilly | US5324571083 | 3.75 | 789.80 | +2.34% | |
AstraZeneca | GB0009895292 | 3.74 | 10,436.0 | -0.57% | |
Boston Scientific | US1011371077 | 3.65 | 103.19 | -0.28% | |
Fresenius SE | DE0005785604 | 3.17 | 40.940 | -1.13% | |
Novo Nordisk B | DK0062498333 | 2.93 | 433.6 | +0.12% | |
AbbVie | US00287Y1091 | 2.63 | 190.58 | +2.25% | |
Insulet | US45784P1012 | 2.62 | 288.27 | -0.59% | |
Thermo Fisher Scientific | US8835561023 | 2.60 | 416.31 | -0.40% | |
RaySearch Labs B | SE0000135485 | 2.57 | 361.50 | 0.00% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pluvalca Disruptive Opportunities A | 107.95M | 3.58 | 0.85 | - | ||
Pluvalca Initiatives PME A | 83.99M | 24.31 | 3.11 | 7.60 | ||
Pluvalca France Small Caps A | 55.73M | 15.20 | 5.05 | 4.70 | ||
Pluvalca Allcaps A | 53M | 8.33 | 9.04 | 5.28 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review